Why is Beta Drugs Ltd falling/rising?

As of 24-Jul, Beta Drugs Ltd is experiencing a decline in its stock price, currently at 1,699.25, reflecting a decrease of 3.7 points or 0.22%. The stock has underperformed its sector by 1.17% today, and while it is higher than its 5-day moving average, it remains below the 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 1.22%, and it has seen a significant drop of 4.80% over the past month. However, on a yearly basis, the stock has increased by 37.18%, indicating strong long-term performance despite recent short-term challenges. Additionally, there has been a rise in investor participation, with delivery volume increasing by 46.51% against the 5-day average, suggesting some interest in the stock despite its current downturn.
In the broader market context, the Sensex has shown a slight decline of 0.20% over the past week and a modest increase of 0.07% over the past month, indicating that the overall market sentiment is relatively stable. However, Beta Drugs Ltd's year-to-date performance is notably poor, with a decline of 10.97% compared to the Sensex's gain of 5.99%. This underperformance in the short term, coupled with the stock's recent price movements, suggests that while there may be some positive investor interest, the overall market conditions and the stock's inability to maintain momentum against its benchmarks are contributing factors to its current decline. The absence of specific positive or negative factors in the dashboard limits further insights into the reasons behind the stock's recent performance.